Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers.

[1]  J. Link,et al.  Screening and kinetic analysis of recombinant anti-CEA antibody fragments. , 1995, Journal of immunological methods.

[2]  D. Segal,et al.  Retargeting of CTL by an efficiently refolded bispecific single-chain Fv dimer produced in bacteria. , 1995, Journal of immunology.

[3]  R. Williams,et al.  Crystal structure of a diabody, a bivalent antibody fragment. , 1994, Structure.

[4]  W. Harris,et al.  Spontaneous assembly of bivalent single chain antibody fragments in Escherichia coli. , 1994, Molecular immunology.

[5]  A. Ketcham,et al.  Radioimmunodetection of colorectal carcinoma using technetium‐99m‐labeled fab′ fragments of the immu‐4 anti‐carcinoembryonic antigen monoclonal antibody , 1994, Cancer.

[6]  E. Voss,et al.  Construction, expression, and activity of a bivalent bispecific single-chain antibody. , 1994, The Journal of biological chemistry.

[7]  R. Raag,et al.  Crystallization of single-chain Fv proteins. , 1993, Journal of molecular biology.

[8]  K. D. Hardman,et al.  An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability. , 1993, Protein engineering.

[9]  A. Scott,et al.  Lesion-by-lesion comparison of computerized tomography and indium-111-labeled monoclonal antibody C110 radioimmunoscintigraphy in colorectal carcinoma: a multicenter trial. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  Terry D. Lee,et al.  Analysis of peptide mixtures by capillary high performance liquid chromatography: A practical guide to small‐scale separations , 1992, Protein science : a publication of the Protein Society.

[11]  G. Winter,et al.  Comparative stabilities in vitro and in vivo of a recombinant mouse antibody FvCys fragment and a bisFvCys conjugate. , 1992, Journal of immunology.

[12]  M. Neumaier,et al.  A monoclonal anti‐idiotypic antibody bearing the image of an epitope specific to the human carcinoembryonic antigen , 1992, International journal of cancer.

[13]  J. Tso,et al.  Formation of a bispecific antibody by the use of leucine zippers. , 1992, Journal of immunology.

[14]  A. Plückthun,et al.  Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli. , 1992, Biochemistry.

[15]  S. Morrison,et al.  In vitro antibodies: strategies for production and application. , 1992, Annual review of immunology.

[16]  T. Teeri,et al.  An active single-chain antibody containing a cellulase linker domain is secreted by Escherichia coli. , 1991, Protein engineering.

[17]  T. Waldmann,et al.  Monoclonal antibodies in diagnosis and therapy , 1991, Science.

[18]  O. Eber,et al.  The immunoscintigraphic use of Tc‐99m‐labelled monoclonal anti‐CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer , 1991, International journal of cancer.

[19]  J. Shively,et al.  Microsequence analysis of peptides and proteins. IX. An improved, compact, automated instrument. , 1991, Analytical biochemistry.

[20]  F. Buchegger,et al.  Iodine-131-labeled MAb F(ab')2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  J. Murray,et al.  Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody. , 1990, Radiology.

[22]  S. Ho,et al.  Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. , 1989, Gene.

[23]  K. D. Hardman,et al.  Single-chain antigen-binding proteins. , 1988, Science.

[24]  R. Paxton,et al.  Tumor uptake as a function of tumor mass: a mathematic model. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  D. Johnson,et al.  Tumor size: effect on monoclonal antibody uptake in tumor models. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  F. Buchegger,et al.  Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. , 1986, The Journal of clinical investigation.

[27]  S. Larson,et al.  Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. , 1983, The Journal of clinical investigation.

[28]  C. Mulhern,et al.  Metastatic colon carcinoma detected with radiolabeled F(ab')2 monoclonal antibody fragments. , 1983, Radiology.

[29]  F. Buchegger,et al.  Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice , 1983, The Journal of experimental medicine.

[30]  C. Wagener,et al.  Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: a systematic approach for the determination of epitope specificities of monoclonal antibodies. , 1983, Journal of immunology.

[31]  P. Fraker,et al.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. , 1978, Biochemical and biophysical research communications.

[32]  J. Coligan,et al.  Isolation and characterization of carcinoembryonic antigen. , 1972, Immunochemistry.

[33]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[34]  L. Wickstrom,et al.  SALMONELLAS IN MEAT. , 1964, Lancet.